| Molecule Generation from Input-Attributions over Graph Convolutional Networks | Jan 25, 2022 | Drug Design | —Unverified | 0 | 0 |
| Antibody DomainBed: Out-of-Distribution Generalization in Therapeutic Protein Design | Jul 15, 2024 | Domain GeneralizationDrug Design | —Unverified | 0 | 0 |
| Navigating the Maize: Cyclic and conditional computational graphs for molecular simulation | Jan 22, 2024 | Active LearningComputational chemistry | —Unverified | 0 | 0 |
| New Candidates for Furin Inhibition as Probable Treat for COVID-19: Docking Output | Jul 27, 2021 | Drug Design | —Unverified | 0 | 0 |
| NLRP3 monomer Functional Dynamics: from the Effects of Allosteric Binding to Implications for Drug Design | Sep 7, 2023 | Drug Design | —Unverified | 0 | 0 |
| Old Drugs for Newly Emerging Viral Disease, COVID-19: Bioinformatic Prospective | Mar 10, 2020 | Drug Design | —Unverified | 0 | 0 |
| One-way Explainability Isn't The Message | May 5, 2022 | Drug Design | —Unverified | 0 | 0 |
| Optimization of Tree Ensembles | May 30, 2017 | Drug Design | —Unverified | 0 | 0 |
| Optimized Drug Design using Multi-Objective Evolutionary Algorithms with SELFIES | May 1, 2024 | Drug DesignEvolutionary Algorithms | —Unverified | 0 | 0 |
| Optimizing Drug Design by Merging Generative AI With Active Learning Frameworks | May 4, 2023 | Active LearningDrug Design | —Unverified | 0 | 0 |
